DrugPatentWatch Database Preview
Alembic Pharms Ltd Company Profile
What is the competitive landscape for ALEMBIC PHARMS LTD, and what generic and branded alternatives to ALEMBIC PHARMS LTD drugs are available?
ALEMBIC PHARMS LTD has eighty approved drugs.
There are five tentative approvals on ALEMBIC PHARMS LTD drugs.
Summary for Alembic Pharms Ltd
| US Patents: | 0 |
| Tradenames: | 70 |
| Ingredients: | 70 |
| NDAs: | 80 |
Drugs and US Patents for Alembic Pharms Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alembic Pharms Ltd | FEBUXOSTAT | febuxostat | TABLET;ORAL | 205421-002 | Jul 1, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Alembic Pharms Ltd | CLONIDINE HYDROCHLORIDE | clonidine hydrochloride | TABLET;ORAL | 091368-001 | Dec 6, 2011 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Alembic Pharms Ltd | IRBESARTAN | irbesartan | TABLET;ORAL | 091236-001 | Oct 15, 2012 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Alembic Pharms Ltd | HYDROCHLOROTHIAZIDE | hydrochlorothiazide | CAPSULE;ORAL | 200645-001 | Nov 30, 2010 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Alembic Pharms Ltd | TADALAFIL | tadalafil | TABLET;ORAL | 204809-004 | Mar 26, 2019 | AB1 | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
